|
Current location: Home » MDi Investors » Avlar
Avlar is a specialist biotechnology venture capital company, which
currently has over £65 million under management in Avlar BioVentures
Fund I and Avlar BioVentures Fund II. The two funds are focused on seed
and early stage investments and are used to invest in emerging
bioscience technologies, notably combinatorial chemistry, functional
genomics, gene and cell therapy and drug design. Avlar works
intensively with companies in the critical stages of development from
pre-formation to second round of financing, applying its strategic,
entrepreneurial and biotech industry skills.
Currently Avlar Bioventures has ten unquoted investments and four publicly quoted investments.
Avlar BioVentures Limited is authorised and regulated by the Financial Services Authority.
www.avlar.com
|
